General Information of Drug (ID: DMEZFXR)

Drug Name
Desoxyribonuclease Drug Info
Indication
Disease Entry ICD 11 Status REF
Female genital tract inflammation GA0Z Approved [1]
Cross-matching ID
TTD Drug ID
DMEZFXR

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Discontinued Drug(s)
Drug(s) Targeting Enzyme unspecific (Enz)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Glutathione DMAHMT9 Human immunodeficiency virus infection 1C62 Approved [3]
VT-1129 DMCGK9H Onchocerciasis 1F6A Phase 2 [4]
HTI-101 DMURXMJ Obesity 5B81 Phase 2 [5]
ASC-101 DMVNCSK Haematological malignancy 2B33.Y Phase 1/2 [6]
BXCL702 DMY9L4C Haematological malignancy 2B33.Y Phase 1 [7]
NZ-1002 DMINSRW Lysosomal storage disease 5C56.Z Terminated [8]
A-11259 DMZ5NQP Bacterial infection 1A00-1C4Z Terminated [9]
SRI-3072 DMBEUN6 Mycobacterium infection 1B10-1B21 Terminated [10]
GW-278884 DMUG82P Colorectal cancer 2B91.Z Terminated [11]
BM-13677 DMKITQN Diabetic complication 5A2Y Terminated [12]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Enzyme unspecific (Enz) TT3C1VN NOUNIPROTAC Modulator [2]

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2 Preparation of the bifunctional enzyme ribonuclease-deoxyribonuclease by cross-linkage. Biochemistry. 1979 Oct 2;18(20):4449-52.
3 Methionine and cysteine affect glutathione level, glutathione-related enzyme activities and the expression of glutathione S-transferase isozymes in rat hepatocytes. J Nutr. 1997 Nov;127(11):2135-41.
4 The clinical candidate VT-1161 is a highly potent inhibitor of Candida albicans CYP51 but fails to bind the human enzyme. Antimicrob Agents Chemother. 2014 Dec;58(12):7121-7.
5 Halozyme Therapeutics Announces New Studies From HTI-101 Presented at Proteoglycan Research Conference. Halozyme Therapeutics. JULY 12, 2006.
6 ClinicalTrials.gov (NCT01983761) Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation. U.S. National Institutes of Health.
7 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
8 Expression of a cytokinin synthesis gene from Agrobacterium tumefaciens T-DNA in basket willow (Salix viminalis). Physiologia Plantarum Volume 88, Issue 3, pages 439-445, July 1993.
9 The Identification of Nanomolar 1,4-benzoquinone Inhibitors of Shikimate Kinase. Aspergillus & Aspergillosis Website. 2002.
10 2-Alkoxycarbonylaminopyridines: inhibitors of Mycobacterium tuberculosis FtsZ. J Antimicrob Chemother. 2002 Jul;50(1):111-4.
11 WO patent application no. 2010,1112,71, Orally bioavailable lipid-based constructs.
12 Progress in medicinal chemistry, 1994. Page(448).